LOADING

Type to search

Seres Therapeutics Taps Alkermes’s von Moltke as Chief Medical Officer

BioTech

Seres Therapeutics Taps Alkermes’s von Moltke as Chief Medical Officer

Share
seres-therapeutics-taps-alkermes’s-von-moltke-as-chief-medical-officer

Xconomy
Boston
— 

Seres Therapeutics (NASDAQ: MCRB) has appointed Lisa von Moltke to serve as its executive vice president and chief medical officer. She is joining the Cambridge, MA-based microbiome drug developer from Alkermes (NASDAQ: ALKS), where she was senior vice president and head of clinical development. Her experience also includes positions at Sanofi (NYSE: SNY) and Takeda Pharmaceutical (NYSE: TAK). The most advanced Seres program, SER-109, is in Phase 3 testing as a treatment for recurrent Clostridium difficile infection.

Underwriters and Partners

Xconomy Insight

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *